RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      대전지역의 요로감염 환자로부터 분리된 요로병인성 대장균 ST131과 Non-ST131의 비교 분석 = Comparative Analysis of Uropathogenic Escherichia coli ST131 and Non-ST131 Isolated from Urinary Tract Infection Patients in Daejeon

      한글로보기

      https://www.riss.kr/link?id=A107193411

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Uropathogenic Escherichia coli (UPEC) is a major cause of urinary tract infections (UTIs), which is one of the most common infectious diseases in humans worldwide. Since UPEC is increasingly gaining resistance to many antimicrobial agents, antibiotic ...

      Uropathogenic Escherichia coli (UPEC) is a major cause of urinary tract infections (UTIs), which is one of the most common infectious diseases in humans worldwide. Since UPEC is increasingly gaining resistance to many antimicrobial agents, antibiotic therapy of UTI has recently become a great concern. This study examined the epidemiological relationship, and antimicrobial resistance patterns of 84 UPEC isolates obtained from UTI patients in Daejeon, from March to December 2017. Molecular epidemiology was investigated by multilocus sequence typing (MLST), and an antimicrobial susceptibility test was determined using an E-test. In this study, UTI was more common in females (73.8%) than in males (26.2%), and the highest incidence of UTI was observed in the age group in their 70s. Among the 84 UPEC isolates, 59 isolates (70.2%) were multidrug-resistant (MDR), and the major sequence type was ST131 (44 isolates, 52.4%). Interestingly, the rates of MDR in non-ST131 isolates (72.5%) were higher compared to ST131 isolates (68.2%). These results indicate the possibility of the development and spread of MDR in non-ST131 isolates. Effective surveillance networks and continuous research need to be conducted globally to prevent the emergence and international spread of MDR non-ST131 isolates.
      Copyright Ⓒ 2020 The Korean Society for Clinical Laboratory Science. All rights reserved.

      더보기

      참고문헌 (Reference)

      1 Amee R. Manges, "Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-Resistant Escherichia coli Clonal Group" Massachusetts Medical Society 345 (345): 1007-1013, 2001

      2 Loh K, "Urinary tract infections in pregnancy" 2 : 54-57, 2007

      3 Norouzian H, "The relationship between phylogenetic groups and antibiotic susceptibility patterns of Escherichia coli strains isolated from feces and urine of patients with acute or recurrent urinary tract infection" 11 : 478-487, 2019

      4 Allan Ronald, "The etiology of urinary tract infection: traditional and emerging pathogens" Elsevier BV 113 (113): 14-19, 2002

      5 Betsy Foxman, "The epidemiology of urinary tract infection" Springer Science and Business Media LLC 7 (7): 653-660, 2010

      6 Hosam M. Zowawi, "The emerging threat of multidrug-resistant Gram-negative bacteria in urology" Springer Science and Business Media LLC 12 (12): 570-584, 2015

      7 B Foxman, "Recurring urinary tract infection: incidence and risk factors." American Public Health Association 80 (80): 331-333, 1990

      8 Thomas M Hooton, "Recurrent urinary tract infection in women" Elsevier BV 17 (17): 259-268, 2001

      9 Donna A Cheung, "Prevalence, co-infection and antibiotic resistance of Escherichia Coli from blood and urine samples at a hospital in Jamaica" Journal of Infection in Developing Countries 14 (14): 146-152, 2020

      10 Abdulaziz Alqasim, "Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia" Elsevier BV 27 (27): 296-302, 2020

      1 Amee R. Manges, "Widespread Distribution of Urinary Tract Infections Caused by a Multidrug-Resistant Escherichia coli Clonal Group" Massachusetts Medical Society 345 (345): 1007-1013, 2001

      2 Loh K, "Urinary tract infections in pregnancy" 2 : 54-57, 2007

      3 Norouzian H, "The relationship between phylogenetic groups and antibiotic susceptibility patterns of Escherichia coli strains isolated from feces and urine of patients with acute or recurrent urinary tract infection" 11 : 478-487, 2019

      4 Allan Ronald, "The etiology of urinary tract infection: traditional and emerging pathogens" Elsevier BV 113 (113): 14-19, 2002

      5 Betsy Foxman, "The epidemiology of urinary tract infection" Springer Science and Business Media LLC 7 (7): 653-660, 2010

      6 Hosam M. Zowawi, "The emerging threat of multidrug-resistant Gram-negative bacteria in urology" Springer Science and Business Media LLC 12 (12): 570-584, 2015

      7 B Foxman, "Recurring urinary tract infection: incidence and risk factors." American Public Health Association 80 (80): 331-333, 1990

      8 Thomas M Hooton, "Recurrent urinary tract infection in women" Elsevier BV 17 (17): 259-268, 2001

      9 Donna A Cheung, "Prevalence, co-infection and antibiotic resistance of Escherichia Coli from blood and urine samples at a hospital in Jamaica" Journal of Infection in Developing Countries 14 (14): 146-152, 2020

      10 Abdulaziz Alqasim, "Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia" Elsevier BV 27 (27): 296-302, 2020

      11 D. J. Schwartz, "Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation" Proceedings of the National Academy of Sciences 110 (110): 15530-15537, 2013

      12 Iranpour D, "Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new clermont phylotyping method" 2015 : 846219-, 2015

      13 Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing; twentieth informa-tional supplement" Clinical and Laboratory Standards Institute 2010

      14 SeyedAbdol Reza Mortazavi-Tabatabaei, "Pattern of antibacterial resistance in urinary tract infections: A systematic review and meta-analysis" Medknow 10 (10): 169-, 2019

      15 Yusuke Matsui, "Multilocus sequence typing of Escherichia coli isolates from urinary tract infection patients and from fecal samples of healthy subjects in a college community" Wiley 9 (9): 1225-1233, 2020

      16 A.-P. Magiorakos, "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance" Elsevier BV 18 (18): 268-281, 2012

      17 Mukherjee M, "Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E" 7 : 449-453, 2013

      18 Laura Fernandes Gonçalves, "Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil" Elsevier BV 6 : 1-4, 2016

      19 Gisele Peirano, "Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4" Elsevier BV 35 (35): 316-321, 2010

      20 Julie Plantamura, "Molecular epidemiological of extended-spectrum β-lactamase producing Escherichia coli isolated in Djibouti" Journal of Infection in Developing Countries 13 (13): 753-758, 2019

      21 Kim Bongyoung, "Molecular Epidemiology of Ciprofloxacin-Resistant Escherichia coli Isolated from Community-Acquired Urinary Tract Infections in Korea" 대한감염학회 52 (52): 194-203, 2020

      22 Jing Wu, "Molecular Characteristics of ST1193 Clone among Phylogenetic Group B2 Non-ST131 Fluoroquinolone-Resistant Escherichia coli" Frontiers Media SA 8 : 2294-, 2017

      23 Nicolas-Chanoine MH, "Intercontinental emergence of Escherichia coli clone O25 : H4-ST131 producing CTX-M-15" 61 : 273-281, 2008

      24 M.-H. Nicolas-Chanoine, "Escherichia coli ST131, an Intriguing Clonal Group" American Society for Microbiology 27 (27): 543-574, 2014

      25 Belayneh Regasa Dadi, "Distribution of virulence genes and phylogenetics of uropathogenic Escherichia coli among urinary tract infection patients in Addis Ababa, Ethiopia" Springer Science and Business Media LLC 20 (20): 108-, 2020

      26 da Cruz Campos, "Determining the Virulence Properties of Escherichia coli ST131 Containing Bacteriocin-Encoding Plasmids Using Short- and Long-Read Sequencing and Comparing Them with Those of Other E. coli Lineages" MDPI AG 7 (7): 534-, 2019

      27 Alghoribi MF, "Antibiotic-resistant ST38, ST131 and ST405 strains are the leading uropathogenic Escherichia coli clones in Riyadh, Saudi Arabia" 70 : 2757-2762, 2015

      28 Atul Kothari, "Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study" Journal of Infection in Developing Countries 2 (2): 354-358, 2008

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2026 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2016-01-01 평가 등재후보학술지 유지 (계속평가) KCI등재후보
      2015-01-08 학술지명변경 한글명 : 대한임상검사학회지 -> 대한임상검사과학회지
      외국어명 : 미등록 -> Korean Journal of Clinical Laboratory Science
      KCI등재후보
      2014-06-25 학회명변경 한글명 : 대한임상검사학회 -> 대한임상검사과학회
      영문명 : The Korean Society for Clinical Laboratory Science -> Korean Society for Clinical Laboratory Science
      KCI등재후보
      2014-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2004-12-17 학회명변경 영문명 : The Korean Society Of Biomedical Laboratory Science -> The Korean Society for Clinical Laboratory Science
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.43 0.43 0.36
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.31 0.28 0.34 0.12
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼